Biotech Amylin to study diabetes drug safety following FDA report
Monday, August 6, 2001
Biotech: CEO Takes Action to Seek Drug Approval
Amylin Pharmaceutical Inc...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know